Stroke. 2005;36:2327-2328
Published online before print September 1, 2005,
doi: 10.1161/01.STR.0000181070.43267.1e
(Stroke. 2005;36:2327.)
© 2005 American Heart Association, Inc.
Acupuncture for Acute Stroke
Shi Hong Zhang, MD;
Ming Liu, MD;
Kjell Asplund, MD, PhD
Lin Li, MD
From the Departments of Neurology (S.H.Z., M.L.) and Acupuncture and Moxibustion (L.L.), West China Hospital, Sichuan University, China; and the National Board of Health and Welfare, Sweden (K.A.).
Correspondence to Professor Ming Liu, MD, Department of Neurology, West China Hospital, Sichuan University, 37 Guo Xue Xiang, Chengdu 610041, China. E-mail wyplmh{at}hotmail.com
Section Editors: Graeme J. Hankey MD, FRCP
Key Words: acupunctur eacute stroke metaanalysis
 |
Introduction
|
|---|
Acupuncture is widely used in the treatment of stroke in China
and it is increasingly requested by patients in some Western
countries. Experimental data indicate that acupuncture-like
sensory stimulation activates multiple efferent (nerve) pathways
leading to altered activity in numerous neural systems.
 |
Objectives
|
|---|
The objectives of this study were to assess the effectiveness
and safety of acupuncture in patients with acute stroke.
 |
Search Strategy
|
|---|
We searched the Cochrane Stroke Group Trials Register (last
searched August 2003), the Chinese Stroke Trials Register (August
2003), and the Chinese Acupuncture Trials Register (August 2003).
Electronic searches were performed in the Cochrane Controlled
Trials Register (The Cochrane Library, Issue 3, 2003), MEDLINE
(1966 to 2003), EMBASE (1980 to 2003), Alternative Medicine
Database (1985 to 2003), CINAHL (1982 to 2003), and the Chinese
Biological Medicine Database (1981 to 2003). Reference lists
of systematic reviews and identified trials were handsearched.
 |
Selection Criteria
|
|---|
Randomized and quasirandomized trials of acupuncture started
within 30 days of stroke onset compared with placebo/sham acupuncture
or open control in patients with acute ischemic and/or hemorrhagic
stroke. Needling into skin was required for acupuncture.
 |
Data Collection and Analysis
|
|---|
Two reviewers selected trials for inclusion, assessed trial
quality, and extracted data independently. Authors of trials
were contacted for missing data. Heterogeneity between trial
results was tested using a standard
2 test.
 |
Main Results
|
|---|
Fourteen trials involving 1208 patients were included. Three
trials were of high quality regarding method of randomization,
concealment of allocation, blinding, and intention-to-treat
analysis. Ten trials included patients with only ischemic stroke.
When acupuncture was compared with sham acupuncture or open
control, there was a borderline significant trend toward fewer
patients being dead or dependent (odds ratio [OR] 0.66, 95%
confidence interval [CI] 0.43 to 0.99;
Figure), and significantly
fewer being dead or needing institutional care (OR 0.58, 95%
CI 0.35 to 0.96) in the acupuncture group after 3 months or
more. There was also a significant difference favoring acupuncture
in the mean change of global neurologic deficit score during
the treatment period (standardized mean difference [SMD] 1.17,
95% CI 0.30 to 2.04). Comparison of acupuncture with sham acupuncture
only showed a statistically significant difference on death
or requiring institutional care (OR 0.49, 95% CI 0.25 to 0.96),
but not on death or dependency (OR 0.67, 95% CI 0.40 to 1.12),
or change of global neurologic deficit score (SMD 0.01, 95%
CI 0.55 to 0.57). Severe adverse events with acupuncture
(dizziness, intolerable pain, and infection of acupoints) were
rare (6 of 386, 1.55%).
 |
Implications for Practice
|
|---|
Acupuncture appeared to be safe. The number of patients is too
small to be certain whether acupuncture is effective for treatment
of acute ischemic or hemorrhagic stroke. The current evidence
does not support the routine use of acupuncture for patients
with acute stroke.
 |
Implications for Research
|
|---|
Because acupuncture appears potentially effective and safe in
the treatment of acute ischemic stroke, further well-designed
trials are required to confirm or refute this. There is also
a need to conduct more randomized, controlled trials of acupuncture
in hemorrhagic stroke. Future trials should overcome the limitations
of many of the trials presented in this review. In particular,
they should ensure adequate concealment of allocation and blinding
of outcome assessors, use an objective dichotomous functional
outcome as a primary outcome, have long-term follow up, and
publish the results in a usable form to facilitate a metaanalysis.
Note: The full text of this review is available in the Cochrane Library (for subscribers http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000119/frame.html). The full article should be cited as: Zhang SH, Liu M, Asplund K, Li L. Acupuncture for acute stroke. Cochrane Database Syst Rev. 2005, Issue 2.
Received June 28, 2005;
accepted July 6, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
B. Wu, M. Liu, H. Liu, W. Li, S. Tan, S. Zhang, and Y. Fang
Meta-Analysis of Traditional Chinese Patent Medicine for Ischemic Stroke
Stroke,
June 1, 2007;
38(6):
1973 - 1979.
[Abstract]
[Full Text]
[PDF]
|
 |
|